ergolide has been researched along with Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Darbandi, A; Gharehbaghian, A; Hamzeloo-Moghadam, M; Karami, A; Mashati, P; Takhviji, V; Yami, A | 1 |
1 other study(ies) available for ergolide and Leukemia
Article | Year |
---|---|
Ergolide, a potent sesquiterpene lactone induces cell cycle arrest along with ROS-dependent apoptosis and potentiates vincristine cytotoxicity in ALL cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Inhibitory Concentration 50; Inula; Lactones; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Sesquiterpenes; Vincristine | 2020 |